⚫INDUCTION TRIALS
☑️ NORAM
☑️ CYCLOPS
☑️ RAVE
☑️ RITUXIVAS
☑️ MEPEX
☑️ MYCYC
☑️ CORTAGE
CYCLOPS ⏩ IV pulse cyclophosphamide 🆚 daily oral cyclophosphamide ⏩ IV pulse not inferior to oral but associated with more relapses
RAVE ⏩ 4 weekly doses of rituximab 🆚 daily oral cyclophosphamide ⏩ Rituximab not inferior
CORTAGE ⏩ Rapid glucocorticoid taper and low dose IV cyclophosphamide 🆚 standard dose cyclophosphamide ⏩ No difference in remission and relapse rates
☑️ CYCAZAREM
☑️ IMPROVE
☑️ WEGENT
☑️ LEM
☑️ WGET
IMPROVE ⏩ oral Mycophenolate mofetil 🆚 oral azathioprine ⏩ more relapses with Mycophenolate
LEM ⏩ leflunomide 🆚 methotrexate ⏩ More adverse events with leflunomide
WGET ⏩ Methotrexate ➕ cyclophosphamide ➕etanercept 🆚 placebo ⏩ increased risk of cancer with etanercept
MAINRITSAN ⏩ Maintenance trial ⏩ Rituximab 🆚 Azathioprine ⏩ Rituximab was superior
RITAZAREM ⏩ Maintenance trial ⏩ Rituximab 🆚 Azathioprine ⏩ Results awaited